Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 249 | 0 | 0 | 303 | 232 |
| Operating Income | -249 | N/A | N/A | -303 | -232 |
| Interest Expense | 9 | 0 | 0 | 6 | 7 |
| Other Income | 764 | 0 | 0 | -841 | 525 |
| Pre-tax Income | 506 | 0 | 0 | -1,150 | 286 |
| Net Income Continuous | 506 | N/A | N/A | -1,150 | 286 |
| Net Income | $506 | $N/A | $N/A | $-1,150 | $286 |
| EPS Basic Total Ops | 0.40 | N/A | N/A | -0.87 | 0.22 |
| EPS Basic Continuous Ops | 0.37 | N/A | N/A | -0.87 | 0.22 |
| EPS Diluted Total Ops | 0.00 | N/A | N/A | -0.87 | 0.22 |
| EPS Diluted Continuous Ops | 0.37 | N/A | N/A | -0.87 | 0.22 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.40 | -0.10 | N/A | N/A |
| EBITDA(a) | $-249 | $N/A | $N/A | $-303 | $-232 |